Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Figure 5.

Figure 5

(A) Particle size and distribution; (B) Zeta potential distribution; (C) TEM micrograph of the optimized AGN-PLHNPs.

HHS Vulnerability Disclosure